Original Research
Published on 16 Sep 2024
Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a multicenter, open-label, randomized, parallel-group comparative study
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
- 2,892 views